Outcome of Board Meeting
Lincoln Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on July 13, 2015, has appointed M/s. J. T. Shah & Co. Chartered Accountants, Ahmedabad as the Statutory Auditors of the Company for the financial year 2015-16 and to hold the office till the conclusion of the next ensuing Annual General Meeting and the said appointment will be subject to the approval of Members at the ensuing Annual General... Board Meeting on July 13, 2015
Lincoln Pharmaceuticals Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on July 13, 2015, to consider the appointment of M/s. J. T. Shah & Co., Chartered Accountants, Ahmedabad as a statutory Auditors in place of existing Statutory Auditors to fill the casual vacancy arose on account of resignation tendered by the existing Statutory Auditors of the Company. Outcome of Board Meeting (EGM on Aug 07, 2015)
Lincoln Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on July 07, 2015, has proposed the name of M/s. J. T. Shah & Co. Chartered Accountants for appointment of Statutory Auditors for the year 2015-16 in place of existing Statutory Auditors M/s. Chandulal M. Shah & Co., who has resigned and also convene Extra Ordinary General Meeting on August 07, 2015 for appointment of Statutory Auditors. Board Meeting on July 07, 2015
Lincoln Pharmaceuticals Ltd has informed BSE that in view of the resignation tendered by the existing Statutory Auditors of the Company M/s. Chandulal M. Shah & Co., a meeting of Board of Directors of the Company is convened on July 07, 2015 to consider the appointment of new Statutory Auditors in place of existing Statutory Auditors to fill the casual vacancy. Code of Conduct of Fair Disclosure
Lincoln Pharmaceuticals Ltd has informed BSE about formulation and adoption of Codes under SEBI (Prohibition of Insider Trading) Regulations, 2015. Demise of Director
Lincoln Pharmaceuticals Ltd has informed BSE that Mr. Maganbhai R. Patel, Director of the Company passed away on May 23, 2015. Updates on Outcome of Board Meeting
Lincoln Pharmaceuticals Ltd has submitted to BSE a copy of the Resolution Passed at the Meeting of the Board of Directors of the Company held on May 30, 2015. Board recommends Dividend
Lincoln Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 30, 2015, inter alia, has:1. Recommended dividend of Re. 1.00(10%) per Equity Share of face value Rs. 10/- each.2. Allotted 36,89,200 warrants convertible in to equal number of Equity shares on preferential basis to the promoters / promoters' group and persons other than the promoters / promoters group pursuant to the... Financial Results for March 31, 2015 (Audited)
Lincoln Pharmaceuticals Ltd has informed BSE about the Financial Results for the period ended March 31, 2015.